Epigenetic coordination of acute systemic inflammation: Potential therapeutic targets

Expert Review of Clinical Immunology

Volumn 10, Issue 9, 2014, Pages 1141-1150

  Vachharajani, Vidula ^a   Liu, Tiefu ^a   McCall, Charles E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

acute inflammation; epigenetics; immunometabolism; leukocyte adhesion; microvascular dysfunction; sepsis; SIRT 1

Indexed keywords

SIRTUIN 1; SIRT1 PROTEIN, HUMAN;

DRUG TARGETING; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; METABOLIC REGULATION; MICROANGIOPATHY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; ANIMAL; CAPILLARY PERMEABILITY; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; METABOLOME; MOLECULARLY TARGETED THERAPY; MOUSE;

ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HOMEOSTASIS; HUMANS; IMMUNOMODULATION; INFLAMMATION; METABOLOME; MICE; MOLECULAR TARGETED THERAPY; SEPSIS; SIRTUIN 1;

EID: 84906051005     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2014.943192     Document Type: Review

References (58)

1. Liu TF, Brown CM, El Gazzar M, et al. Fueling the flame: bioenergy couples metabolism and inflammation. J Leukoc Biol 2012;92(3):499-507
2. Daniels R. Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective). J Antimicrob Chemother 2011;66(Suppl 2):ii11-23
3. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369(9):840-51
4. Williams SC. After Xigris, researchers look to new targets to combat sepsis. Nat Med 2012;18(7):1001
5. Horsthemke B. Waddington's epigenetic landscape and post-Darwinian biology. Bioessays 2012;34(8):711-12
6. Slack JM. Conrad Hal Waddington: the last Renaissance biologist? Nat Rev Genetics 2002;3(11):889-95
7. Carson WF, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 2011;6(3): 273-83
8. Osuchowski MF, Craciun F, Weixelbaumer KM, et al. Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol 2012;189(9):4648-56
9. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012;72(6): 1491-501
10. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011;208(13):2581-90
11. Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 2014;5(1):45-56
12. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007;447(7147):972-8
13. Megee PC, Morgan BA, Mittman BA, Smith MM. Genetic analysis of histone H4: essential role of lysines subject to reversible acetylation. Science 1990;247(4944):841-5
14. El Gazzar M, Liu T, Yoza BK, McCall CE. Dynamic and selective nucleosome repositioning during endotoxin tolerance. J Biol Chem 2010;285(2):1259-71
15. Natoli G. Tuning up inflammation: how DNA sequence and chromatin organization control the induction of inflammatory genes by NF-kappaB. FEBS lett 2006;580(12): 2843-9
16. Smale ST. Selective transcription in response to an inflammatory stimulus. Cell 2010;140(6):833-44
17. McCall CE, El Gazzar M, Liu T, et al. Epigenetics, bioenergetics, and microRNA coordinate gene-specific reprogramming during acute systemic inflammation. J Leukoc Biol 2011;90(3): 439-46
18. Yan Q, Carmody RJ, Qu Z, et al. Nuclear factor-kappaB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome. Proc Natl Acad Sci USA 2012;109(35):14140-5
19. Chen X, El Gazzar M, Yoza BK, McCall CE. The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem 2009;284(41):27857-65
20. Wysocka M, Montaner LJ, Karp CL. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis. J Immunol 2005;174(11):7398-402
21. Unsinger J, Kazama H, McDonough JS, et al. Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J Immunol 2010;184(12):6766-72
22. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57(12):3239-46
23. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-46
24. Gillum MP, Kotas ME, Erion DM, et al. SirT1 regulates adipose tissue inflammation. Diabetes 2011;60(12):3235-45
25. Infantino V, Convertini P, Cucci L, et al. The mitochondrial citrate carrier: a new player in inflammation. Biochem J 2011; 438(3):433-6
26. O'Neill LA. A critical role for citrate metabolism in LPS signalling. Biochem J 2011;438(3):e5-6
27. Barke RA, Brady PS, Brady LJ. The Ca2+ second messenger system and interleukin-1-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation. Surgery 1991;110(2):285-94
28. Liu TF, Vachharajani VT, Yoza BK, McCall CE. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem 2012; 287(31):25758-69
29. Odegaard JI, Chawla A. The immune system as a sensor of the metabolic state. Immunity 2013;38(4):644-54
30. Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity 2007;27(2):173-8
31. Wellen KE, Thompson CB. Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell 2010; 40(2):323-32
32. Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 2010;22(3):314-20
33. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324(5930): 1029-33
34. Peyssonnaux C, Datta V, Cramer T, et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005;115(7):1806-15
35. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008; 453(7196):807-11
36. Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007; 462(2):245-53
37. Singer M. Cellular dysfunction in sepsis. Clin Chest Med 2008;29(4):655-60.viii-ix
38. Bhatt AP, Jacobs SR, Freemerman AJ, et al. Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci USA 2012;109(29):11818-23
39. Kubes P, Suzuki M, Granger DN. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. Am J Physiol 1990;258(1 Pt 1): G158-63
40. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88(11):4651-5
41. Jung U, Norman KE, Scharffetter-Kochanek K, et al. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest 1998; 102(8):1526-33
42. Davies PF, Manduchi E, Stoeckert CJ, et al. Emerging topic: flow-related epigenetic regulation of endothelial phenotype through DNA methylation. Vascul Pharmacol 2014. [Epub ahead of print]
43. Xu Y. Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective. J Biomed Res 2014;28(1):47-52
44. Zhou J, Li YS, Wang KC, Chien S. Epigenetic mechanism in regulation of endothelial function by disturbed flow: induction of DNA hypermethylation by DNMT1. Cell Mol Bioeng 2014;7(2): 218-24
45. Chen D, Fang F, Yang Y, et al. Brahma-related gene 1 (Brg1) epigenetically regulates CAM activation during hypoxic pulmonary hypertension. Cardiovasc Res 2013;100(3):363-73
46. Vachharajani V, Cunningham C, Yoza B, et al. Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity 2012;20(3): 498-504
47. Vachharajani V, Russell JM, Scott KL, et al. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 2005; 12(2):183-94
48. Vachharajani V, Vital S, Russell J, Granger DN. Hypertonic saline and the cerebral microcirculation in obese septic mice. Microcirculation 2007;14(3):223-31
49. Vachharajani V, Vital S, Russell J, et al. Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice. Microcirculation 2006; 13(6):477-87
50. Vachharajani V, Wang SW, Mishra N, et al. Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation 2010;17(6):407-16
51. Vachharajani VT, Fu Liu T, Brown CM, et al. SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. Journal of leukocyte biology, Jul 7 2014.
52. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30(10):475-87
53. Kox M, de Kleijn S, Pompe JC, et al. Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. Crit Care Med 2011;39(8): 1866-70
54. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000;403(6771): 795-800
55. Sinclair DA, Guarente L. Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol 2014;54:363-80
56. Liu TF, Yoza BK, El Gazzar M, et al. NAD +-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem 2011; 286(11):9856-64
57. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23(12): 2369-80
58. Vaquero A, Scher M, Lee D, et al. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol cell 2004;16(1): 93-105